Casdin Capital
Alexandria Fisk, COO, joined Casdin Capital in 2019. Alex has spent the last 4 years as a consultant and advisor to growth focused companies including Casdin Capital, where she has worked closely with the Investment Team over the last 12 months.
Prior to joining Casdin, Alex ran her own consultancy business working with technology companies as an advisor on strategy and advancing performance. Previously, Alex worked for a high growth start up as a General Manager of a $100m product line. Alex began her career at UBS as a Business Analyst in London and ended her time based in New York as the COO of the Macro Research Division.
Alex holds a B.A (Hons) in Management from the University of Nottingham, she is CIMA qualified and holds a Masters in Integrated Marketing from NYU.
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.